Breckenridge Pharma

News

Click on news to view details.

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 2.5 and 10mg Strengths (generic for Saphris®)

[ December 11, 2020 ]

Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules (generic for Pomalyst®)

[ November 13, 2020 ]

Towa completes acquisition of Esteve's Generic Division

[ January 31, 2020 ]

Rivastigmine Transdermal System Approval

[ December 02, 2019 ]

Final Approval of ANDA for Erlotinib Hydrochloride Tablets

[ November 12, 2019 ]

Imatinib approval announcement

[ March 04, 2019 ]

View All News

View Archrive News